Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Currently, Flatiron partners with over 265 community cancer clinics, six major academic research centers and 14 out of the top 15 therapeutic oncology companies. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Therefore, since Flatiron started in 2012, it has grown to nearly […] "As a leading technology company in oncology, Flatiron Health is best positioned to provide the technology and data analytics infrastructure needed not only for Roche but for oncology research and development efforts across the entire industry.". Daniel O’Day, CEO Roche Pharmaceuticals said, “This is an important step in our personalised healthcare strategy for Roche, as we believe that regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments. | February 16, 2018 -- 11:43 GMT (03:43 PST) Swiss pharmaceutical giant Roche Group is buying Flatiron Health, an Alphabet-backed cancer-focused start-up founded by two former Google employees, according to sources familiar with the matter. You may unsubscribe from these newsletters at any time. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company has developed an information exchange platform which allows "researchers and care providers to learn from the experience of every patient. paved ", In a blog post, Turner, Flatiron Health co-founder and CEO said that the acquisition represents a "major milestone in a yet-to-be-finished story. Learn more about Flatiron's mission, vision and story. Roche completes acquisition of Flatiron Health, Roche to acquire Flatiron Health to accelerate…, BD Completes Bard Acquisition, Creating New Global…, Biotage completes the acquisition of PhyNexus, Inc.…. As part of the deal, Roche agreed to acquire several of the company's software products, which was intended to put the company in a position to go public. Contactless checkout: Why it's coming to the bodega before the chain store. Market data provided by Interactive Data. be. The Flatiron platform enables cancer researchers and care providers to learn from the experience of every patient. Roche completes acquisition of Flatiron Health. So they're making their own plans for the future instead. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well … The company will pay $1.9 billion, adding to its existing stake, for a total value of $2.1 billion. The parties expect that following the closing, Flatiron Health will continue its current business model, network of partnerships and overall objectives. OLED This important milestone will allow us to increase our investments in our provider-facing technology and services platform, as well as our evidence-generation platform, which will remain available to the entire healthcare industry.”.